Murali S.

Murali S. has been working in the field of analytical and formulations development since 2009. Murali began their career at Biocon Research Limited, where they held the positions of Scientist, Senior Scientist, Principal Scientist, and Associate Scientific Manager. In 2017, they moved to Apotex Inc. as a Group Leader - Product Development, Apobiologix. In 2018, they were a Group Leader - R&D Analytical at Taro Pharmaceuticals. In 2019, they became a Manager - Analytical & Formulations Development at Phoena. Most recently, in 2021, they were appointed Director - Analytical Development at Providence Therapeutics.

Murali S. is currently a PhD candidate in Analytical Chemistry at Louisiana State University. Previously, they obtained a Masters in Chemistry from the University at Buffalo and a Bachelors in Chemistry from Michigan Technological University. Murali also holds a certification in Bioscience Management from the Keck Graduate Institute.